Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 10/2010

01.10.2010 | Original Paper

Perineural invasion in carcinoma of the cervix uteri—prognostic impact

verfasst von: Lars-Christian Horn, Alexandra Meinel, Uta Fischer, Karl Bilek, Bettina Hentschel

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Limited information exists about the occurrence and the impact of perineural invasion (PNI) in patients with cervical carcinoma (CX).

Methods

The original histologic slides from patients primarily treated by radical hysterectomy and systematic pelvic lymphadenectomy were re-examined regarding the occurrence of PNI. PNI was correlated to recurrence free (RFS) and overall survival (OS).

Results

35.1% of all patients (68/194) represented perineural invasion (=PNI). The 5-year-overall-survival-rate was significantly decreased in patients representing PNI, when they were compared with those without PNI (51.1% [95% CI 38.0–64.2] vs. 75.6% [95% CI 67.8–83.4]; p = 0.001). In a separate analysis the prognostic impact persisted in the node negative, but disappeared in the node-positive cases. In multivariate analysis, pelvic lymph node involvement and PNI were independent prognostic factors for overall survival.

Conclusions

Perineural invasion is seen in about one-third of patients with cervical carcinoma. Patients affected by PNI represented a decreased overall survival. Further studies are required to get a deeper insight into the clinical impact and the pathogenetic mechanisms of PNI in CX.
Literatur
Zurück zum Zitat Bae SE, Corcoran BM, Watson ED (2001) Immunohistochemical study of the distribution of adrenergic and peptidergic innervation in the equine uterus and the cervix. Reproduction 122:275–282CrossRefPubMed Bae SE, Corcoran BM, Watson ED (2001) Immunohistochemical study of the distribution of adrenergic and peptidergic innervation in the equine uterus and the cervix. Reproduction 122:275–282CrossRefPubMed
Zurück zum Zitat Batsakis JG (1985) Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol 94:426–427PubMed Batsakis JG (1985) Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol 94:426–427PubMed
Zurück zum Zitat Beitler JJ, Anderson PS, Wadler S, Runowicz CD, Hayes MK, Fields AL, Sood B, Goldberg GL (1997) Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival? Int J Radiat Oncol Biol Phys 38:143–148PubMed Beitler JJ, Anderson PS, Wadler S, Runowicz CD, Hayes MK, Fields AL, Sood B, Goldberg GL (1997) Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival? Int J Radiat Oncol Biol Phys 38:143–148PubMed
Zurück zum Zitat Dalal R, Djakiew D (1997) Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol Cell Endocrinol 134:15–22CrossRefPubMed Dalal R, Djakiew D (1997) Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol Cell Endocrinol 134:15–22CrossRefPubMed
Zurück zum Zitat Dunn M, Morgan MB, Beer TW (2009) Perineural invasion: identification, significance, and a standardized definition. Dermatol Surg 35:214–221CrossRefPubMed Dunn M, Morgan MB, Beer TW (2009) Perineural invasion: identification, significance, and a standardized definition. Dermatol Surg 35:214–221CrossRefPubMed
Zurück zum Zitat Fellegara G, Kuhn E (2007) Perineural and intraneural “invasion” in benign proliferative breast disease. Int J Surg Pathol 15:286–287CrossRefPubMed Fellegara G, Kuhn E (2007) Perineural and intraneural “invasion” in benign proliferative breast disease. Int J Surg Pathol 15:286–287CrossRefPubMed
Zurück zum Zitat Gil Z, Carlson DL, Gupta A, Lee N, Hoppe B, Shah JP, Kraus DH (2009) Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 135:173–179CrossRefPubMed Gil Z, Carlson DL, Gupta A, Lee N, Hoppe B, Shah JP, Kraus DH (2009) Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 135:173–179CrossRefPubMed
Zurück zum Zitat Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, Mason MD (2007) The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer 109:13–24CrossRefPubMed Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, Mason MD (2007) The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer 109:13–24CrossRefPubMed
Zurück zum Zitat Hassanein AM, Proper SA, Depcik-Smith ND, Flowers FP (2005) Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery. Dermatol Surg 31:1101–1106CrossRefPubMed Hassanein AM, Proper SA, Depcik-Smith ND, Flowers FP (2005) Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery. Dermatol Surg 31:1101–1106CrossRefPubMed
Zurück zum Zitat Horn LC, Bilek K (2001) Cancer register for cervix carcinoma—useful and necessary? Zentralbl Gynakol 123:311–314CrossRefPubMed Horn LC, Bilek K (2001) Cancer register for cervix carcinoma—useful and necessary? Zentralbl Gynakol 123:311–314CrossRefPubMed
Zurück zum Zitat Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Riethdorf L, Schnurch HG, Schmidt D (2005) Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies. Pathologe 26:266–272CrossRefPubMed Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Riethdorf L, Schnurch HG, Schmidt D (2005) Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies. Pathologe 26:266–272CrossRefPubMed
Zurück zum Zitat Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Reich O, Riethdorf L, Schmidt D (2007a) Pathoanatomical preparation and reporting for dysplasias and cancers of the cervix uteri: cervical biopsy, conization, radical hysterectomy and exenteration. Pathologe 28:249–260CrossRefPubMed Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Reich O, Riethdorf L, Schmidt D (2007a) Pathoanatomical preparation and reporting for dysplasias and cancers of the cervix uteri: cervical biopsy, conization, radical hysterectomy and exenteration. Pathologe 28:249–260CrossRefPubMed
Zurück zum Zitat Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B (2007b) Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107:310–315CrossRefPubMed Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B (2007b) Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107:310–315CrossRefPubMed
Zurück zum Zitat Ketterer K, Rao S, Friess H, Weiss J, Büchler MW, Korc M (2003) Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 9:5127–5136PubMed Ketterer K, Rao S, Friess H, Weiss J, Büchler MW, Korc M (2003) Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 9:5127–5136PubMed
Zurück zum Zitat Kurman RJ, Amin MB (1999) Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with carcinomas of the cervix. A basis for checklists. Arch Pathol Lab Med 123:55–61PubMed Kurman RJ, Amin MB (1999) Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with carcinomas of the cervix. A basis for checklists. Arch Pathol Lab Med 123:55–61PubMed
Zurück zum Zitat Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM (2007) Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys 68:1059–1064PubMed Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM (2007) Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys 68:1059–1064PubMed
Zurück zum Zitat Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009) Perineural invasion in cancer: a review of the literature. Cancer 115:3379–3391CrossRefPubMed Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009) Perineural invasion in cancer: a review of the literature. Cancer 115:3379–3391CrossRefPubMed
Zurück zum Zitat Limawararut V, Leibovitch I, Sullivan T, Selva D (2007) Periocular squamous cell carcinoma. Clin Experiment Ophthalmol 35:174–185PubMed Limawararut V, Leibovitch I, Sullivan T, Selva D (2007) Periocular squamous cell carcinoma. Clin Experiment Ophthalmol 35:174–185PubMed
Zurück zum Zitat Memarzadeh S, Natarajan S, Dandade DP, Ostrzega N, Saber PA, Busuttil A, Lentz SE, Berek JS (2003) Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet Gynecol 102:612–619CrossRefPubMed Memarzadeh S, Natarajan S, Dandade DP, Ostrzega N, Saber PA, Busuttil A, Lentz SE, Berek JS (2003) Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet Gynecol 102:612–619CrossRefPubMed
Zurück zum Zitat Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, Duvillard P (1999) Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 73:106–110CrossRefPubMed Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, Duvillard P (1999) Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 73:106–110CrossRefPubMed
Zurück zum Zitat Ozan H, Bilgin T, Celik N, Erol O, Ediz B (2004) The importance of perineural invasion in cervical cancer. Int J Gynecol Cancer 14:731 Ozan H, Bilgin T, Celik N, Erol O, Ediz B (2004) The importance of perineural invasion in cervical cancer. Int J Gynecol Cancer 14:731
Zurück zum Zitat Pieterse QD, Kenter GG, Eilers PH, Trimbos JB (2008) An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model. Int J Gynecol Cancer 18:432–438CrossRefPubMed Pieterse QD, Kenter GG, Eilers PH, Trimbos JB (2008) An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model. Int J Gynecol Cancer 18:432–438CrossRefPubMed
Zurück zum Zitat Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265–272PubMed Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265–272PubMed
Zurück zum Zitat Sartori E, Tisi G, Chiudinelli F, La Face B, Franzini R, Pecorelli S (2007) Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol 107:170–174CrossRef Sartori E, Tisi G, Chiudinelli F, La Face B, Franzini R, Pecorelli S (2007) Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol 107:170–174CrossRef
Zurück zum Zitat Singh N, Arif S (2004) Histopathologic parameters of prognosis in cervical cancer—a review. Int J Gynecol Cancer 14:741–775CrossRefPubMed Singh N, Arif S (2004) Histopathologic parameters of prognosis in cervical cancer—a review. Int J Gynecol Cancer 14:741–775CrossRefPubMed
Zurück zum Zitat Sobin LH, Wittekind C (2002) TNM-classification of malignant tumors, 6th edn. Wiley-Liss, London Sobin LH, Wittekind C (2002) TNM-classification of malignant tumors, 6th edn. Wiley-Liss, London
Zurück zum Zitat Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Shimamoto F, Sueda T (2008) Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma. Dig Dis Sci 53:2281–2286CrossRefPubMed Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Shimamoto F, Sueda T (2008) Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma. Dig Dis Sci 53:2281–2286CrossRefPubMed
Zurück zum Zitat Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S (2002) Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81:1144–1151PubMed Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S (2002) Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81:1144–1151PubMed
Zurück zum Zitat Tingåker BK, Ekman-Ordeberg G, Facer P, Irestedt L, Anand P (2008) Influence of pregnancy and labor on the occurrence of nerve fibers expressing the capsaicin receptor TRPV1 in human corpus and cervix uteri. Reprod Biol Endocrinol 12:6–8 Tingåker BK, Ekman-Ordeberg G, Facer P, Irestedt L, Anand P (2008) Influence of pregnancy and labor on the occurrence of nerve fibers expressing the capsaicin receptor TRPV1 in human corpus and cervix uteri. Reprod Biol Endocrinol 12:6–8
Zurück zum Zitat Trimbos JB, Lambeek AF, Peters AA, Wolterbeek R, Gaarenstroom KN, Fleuren GJ, Kenter GG (2004) Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer. Gynecol Oncol 95:77–81CrossRefPubMed Trimbos JB, Lambeek AF, Peters AA, Wolterbeek R, Gaarenstroom KN, Fleuren GJ, Kenter GG (2004) Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer. Gynecol Oncol 95:77–81CrossRefPubMed
Zurück zum Zitat Wells M, Östör AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, Goodman AK, Sankaranayanan R, Hanselaar AG, Albores-Saavedra J (2003) Epithelial tumors of the uterine cervix. In: Tavassoli FA, Devilee P (eds) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classification of Tumours. IARC Press, Lyon, pp 259–279 Wells M, Östör AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, Goodman AK, Sankaranayanan R, Hanselaar AG, Albores-Saavedra J (2003) Epithelial tumors of the uterine cervix. In: Tavassoli FA, Devilee P (eds) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classification of Tumours. IARC Press, Lyon, pp 259–279
Zurück zum Zitat Yokoyama Y, Nishio H, Ebata T, Abe T, Igami T, Oda K, Nimura Y, Nagino M (2008) New classification of cystic duct carcinoma. World J Surg 32:621–626CrossRefPubMed Yokoyama Y, Nishio H, Ebata T, Abe T, Igami T, Oda K, Nimura Y, Nagino M (2008) New classification of cystic duct carcinoma. World J Surg 32:621–626CrossRefPubMed
Metadaten
Titel
Perineural invasion in carcinoma of the cervix uteri—prognostic impact
verfasst von
Lars-Christian Horn
Alexandra Meinel
Uta Fischer
Karl Bilek
Bettina Hentschel
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 10/2010
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-010-0813-z

Weitere Artikel der Ausgabe 10/2010

Journal of Cancer Research and Clinical Oncology 10/2010 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.